The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal Antibodies
|
|---|---|
| Published in |
Frontiers in Pharmacology, June 2016
|
| DOI | 10.3389/fphar.2016.00193 |
| Pubmed ID | |
| Authors |
Evelien Moorkens, Clara Jonker-Exler, Isabelle Huys, Paul Declerck, Steven Simoens, Arnold G. Vulto |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 2 | 25% |
| United Kingdom | 1 | 13% |
| Canada | 1 | 13% |
| Unknown | 4 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 88% |
| Science communicators (journalists, bloggers, editors) | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 206 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Ecuador | 1 | <1% |
| Unknown | 205 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 52 | 25% |
| Researcher | 21 | 10% |
| Student > Ph. D. Student | 21 | 10% |
| Student > Bachelor | 21 | 10% |
| Other | 13 | 6% |
| Other | 21 | 10% |
| Unknown | 57 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 50 | 24% |
| Biochemistry, Genetics and Molecular Biology | 16 | 8% |
| Economics, Econometrics and Finance | 16 | 8% |
| Medicine and Dentistry | 15 | 7% |
| Agricultural and Biological Sciences | 9 | 4% |
| Other | 36 | 17% |
| Unknown | 64 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 September 2018.
All research outputs
#7,336,491
of 25,837,817 outputs
Outputs from Frontiers in Pharmacology
#3,267
of 20,002 outputs
Outputs of similar age
#111,747
of 370,914 outputs
Outputs of similar age from Frontiers in Pharmacology
#26
of 125 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 20,002 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 370,914 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 125 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.